Berko Milleit

459 total citations
14 papers, 357 citations indexed

About

Berko Milleit is a scholar working on Biological Psychiatry, Psychiatry and Mental health and Physiology. According to data from OpenAlex, Berko Milleit has authored 14 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Biological Psychiatry, 7 papers in Psychiatry and Mental health and 5 papers in Physiology. Recurrent topics in Berko Milleit's work include Tryptophan and brain disorders (7 papers), Schizophrenia research and treatment (6 papers) and Diet and metabolism studies (4 papers). Berko Milleit is often cited by papers focused on Tryptophan and brain disorders (7 papers), Schizophrenia research and treatment (6 papers) and Diet and metabolism studies (4 papers). Berko Milleit collaborates with scholars based in Germany, Australia and Austria. Berko Milleit's co-authors include Stefan Smesny, Heinrich Sauer, G. Paul Amminger, Igor Nenadić, Christian Gaser, Patrick D. McGorry, Uta‐Christina Hipler, Claudia M. Klier, Gregor Berger and Michael Berk and has published in prestigious journals such as PLoS ONE, NeuroImage and Neuroscience.

In The Last Decade

Berko Milleit

14 papers receiving 352 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Berko Milleit Germany 11 123 103 100 78 54 14 357
Nihit Kumar United States 4 89 0.7× 74 0.7× 79 0.8× 40 0.5× 15 0.3× 8 387
T. Easton United Kingdom 8 75 0.6× 105 1.0× 83 0.8× 127 1.6× 139 2.6× 12 361
Kyoko Hasebe Australia 11 97 0.8× 41 0.4× 62 0.6× 65 0.8× 25 0.5× 20 299
M. Schroeter Germany 8 44 0.4× 104 1.0× 72 0.7× 62 0.8× 14 0.3× 10 322
Franz Hozer France 8 84 0.7× 93 0.9× 42 0.4× 41 0.5× 17 0.3× 14 286
Edemilson Mariot Brazil 10 107 0.9× 153 1.5× 121 1.2× 62 0.8× 12 0.2× 12 357
Craig J. Hudson Canada 10 93 0.8× 201 2.0× 199 2.0× 107 1.4× 66 1.2× 14 557
Dana Kilroy Ireland 6 46 0.4× 113 1.1× 48 0.5× 87 1.1× 49 0.9× 6 369
Camila M. Santos Brazil 13 76 0.6× 135 1.3× 65 0.7× 27 0.3× 17 0.3× 16 376
Chantel Kowalchuk Canada 9 95 0.8× 174 1.7× 106 1.1× 122 1.6× 17 0.3× 18 422

Countries citing papers authored by Berko Milleit

Since Specialization
Citations

This map shows the geographic impact of Berko Milleit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Berko Milleit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Berko Milleit more than expected).

Fields of papers citing papers by Berko Milleit

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Berko Milleit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Berko Milleit. The network helps show where Berko Milleit may publish in the future.

Co-authorship network of co-authors of Berko Milleit

This figure shows the co-authorship network connecting the top 25 collaborators of Berko Milleit. A scholar is included among the top collaborators of Berko Milleit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Berko Milleit. Berko Milleit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Schmidt, Michaela, A.C. Rossetti, Christiane Brandwein, et al.. (2021). Brain Derived Neurotrophic Factor Deficiency is Associated with Cognitive Impairment and Elevated Phospholipase A2 Activity in Plasma of Mice. Neuroscience. 480. 167–177. 5 indexed citations
2.
Langbein, Kerstin, Alexander Gussew, Berko Milleit, et al.. (2017). Disturbed glutathione antioxidative defense is associated with structural brain changes in neuroleptic-naïve first-episode psychosis patients. Prostaglandins Leukotrienes and Essential Fatty Acids. 136. 103–110. 21 indexed citations
3.
Smesny, Stefan, Berko Milleit, Miriam Schaefer, et al.. (2017). Effects of omega-3 PUFA on immune markers in adolescent individuals at ultra-high risk for psychosis – Results of the randomized controlled Vienna omega-3 study. Schizophrenia Research. 188. 110–117. 18 indexed citations
4.
McNamara, Robert K., Philip R. Szeszko, Stefan Smesny, et al.. (2016). Polyunsaturated fatty acid biostatus, phospholipase A2 activity and brain white matter microstructure across adolescence. Neuroscience. 343. 423–433. 8 indexed citations
5.
Milleit, Berko, Stefan Smesny, Matthias Rothermundt, et al.. (2016). Serum S100B Protein is Specifically Related to White Matter Changes in Schizophrenia. Frontiers in Cellular Neuroscience. 10. 33–33. 27 indexed citations
6.
Berger, Gregor, Stefan Smesny, Miriam R. Schäfer, et al.. (2016). Niacin Skin Sensitivity Is Increased in Adolescents at Ultra-High Risk for Psychosis. PLoS ONE. 11(2). e0148429–e0148429. 39 indexed citations
7.
Smesny, Stefan, Alexander Gussew, Mario Walther, et al.. (2015). Glutamatergic dysfunction linked to energy and membrane lipid metabolism in frontal and anterior cingulate cortices of never treated first-episode schizophrenia patients. Schizophrenia Research. 168(1-2). 322–329. 33 indexed citations
8.
Smesny, Stefan, Berko Milleit, Miriam Schaefer, et al.. (2015). Effects of omega-3 PUFA on the vitamin E and glutathione antioxidant defense system in individuals at ultra-high risk of psychosis. Prostaglandins Leukotrienes and Essential Fatty Acids. 101. 15–21. 30 indexed citations
9.
Smesny, Stefan, Berko Milleit, U.‐C. Hipler, et al.. (2013). Omega-3 fatty acid supplementation changes intracellular phospholipase A2 activity and membrane fatty acid profiles in individuals at ultra-high risk for psychosis. Molecular Psychiatry. 19(3). 317–324. 55 indexed citations
10.
Smesny, Stefan, Christian E.H. Schmelzer, Christiane Schneider, et al.. (2012). Skin Ceramide Alterations in First-Episode Schizophrenia Indicate Abnormal Sphingolipid Metabolism. Schizophrenia Bulletin. 39(4). 933–941. 36 indexed citations
11.
Smesny, Stefan, Berko Milleit, Igor Nenadić, et al.. (2010). Phospholipase A2 activity is associated with structural brain changes in schizophrenia. NeuroImage. 52(4). 1314–1327. 35 indexed citations
12.
Smesny, Stefan, Ingo Willhardt, J. Lasch, et al.. (2010). Phospholipase A2activity in first episode schizophrenia: Associations with symptom severity and outcome at week 12. The World Journal of Biological Psychiatry. 12(8). 598–607. 22 indexed citations
13.
Milleit, Berko, Uta‐Christina Hipler, André Köhler, et al.. (2010). NIACIN SKIN FLUSH RESPONSE IN SCHIZOPHRENIA LINKED TO SOLUBLE INTERLEUKIN 2 RECEPTOR SERUM LEVELS. Schizophrenia Research. 117(2-3). 486–487. 1 indexed citations
14.
Zwick, Ernst B., Lutz Leistritz, Berko Milleit, et al.. (2003). Classification of equinus in ambulatory children with cerebral palsy - discrimination between dynamic tightness and fixed contracture. Gait & Posture. 20(3). 273–279. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026